Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Updated on: December 18,2023

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Updated on:December 18,2023

New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on: December 22,2023

New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on:December 22,2023

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on: November 10,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on:November 10,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may

Updated on: December 25,2023

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may

Updated on:December 25,2023

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc

Updated on: January 04,2024

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc

Updated on:January 04,2024

Researchers identify possible new combination treatment for advanced melanoma

by University of California, Los AngelesMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A study by researchers at

Updated on: April 22,2024

Researchers identify possible new combination treatment for advanced melanoma

by University of California, Los AngelesMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A study by researchers at

Updated on:April 22,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on: January 08,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on:January 08,2024

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on: December 18,2023

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on:December 18,2023

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the

Updated on: January 04,2024

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the

Updated on:January 04,2024

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on: April 28,2024

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on:April 28,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on: June 22,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on:June 22,2024